Get Even More Visitors To Your Blog, Upgrade To A Business Listing >>

Pharma Testing Outsourcing Market: 8.4% CAGR and Cost-Effective Models

Highlighted with 83 tables and 83 figures, this 164-page report “Global Pharmaceutical Analytical Testing Outsourcing Market 2022-2031 by Service Type (Bioanalytical Testing, Method Development and Validation, Stability Testing, Others), Product Type (Raw Materials & Additives, APIs, Finished Products), End User (Pharma & Biopharma Companies, CMOs, Others), Organization Size (SMEs, Large Enterprises), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global pharmaceutical analytical testing outsourcing market and all its sub-segments through extensively detailed classifications.

Global pharmaceutical Analytical Testing Outsourcing market will reach $16,527.5 million by 2031, growing by 8.4% annually over 2022-2031, driven by the increasing pipelines for drug candidates, rising demand for additional analytical details on drugs as well as process development by regulatory agencies, entry of new contract organizations, and the lack of in-house equipment along with the rising adoption of outsourcing activities.

This can be attributed to factors such as the increasing need for efficiency and quality control in the industry, the rising demand for labor-saving technology, and the growing focus on automation and robotics in manufacturing processes.

The report provides a comprehensive overview of the Pharmaceutical Analytical Testing Outsourcing Market on an overall and country level. It also focuses on various key industry players in the market, which are covered in detail across various levels of the value chain, to provide an overview of their current business and financials, future growth prospects and strategies.

Request Research Sample with Latest Industry Insights (164+ Pages Report): https://altusmarketresearch.com/reports/sample/43098

Based on Service Type, the global pharmaceutical analytical testing outsourcing market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Bioanalytical Testing
o Clinical Testing
o Non-clinical Testing
• Method Development and Validation
o Extractable & Leachable
o Impurity Method
o Technical Consulting
o Other Methods
• Stability Testing
o Drug Substances Testing
o Accelerated Stability Testing
o Photostability Testing
o Other Stability Testings
• Other Services

Based on Product, the global pharmaceutical analytical testing outsourcing market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Raw Materials & Additives
• Active Pharmaceutical Ingredients (APIs)
• Finished Products

By End User, the global pharmaceutical analytical testing outsourcing market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• Pharmaceutical & Biopharmaceutical Companies
• Contract Manufacturing Organizations (CMOs)
• Other End Users

By Organization Size, the global pharmaceutical analytical testing outsourcing market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2031 included in each section.

• SMEs
• Large Enterprises

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Russia, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE,Saudi Arabia, South Africa and Rest of MEA)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2022-2031. The breakdown of all regional markets by country and split of each national market by Service Type, End User and Organization Size over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including pharmaceutical analytical Testing Outsourcing market leaders and important emerging players.

Selected Key Players:

Boston Analytical, Inc.
Charles River Laboratories International, Inc.
Eurofins Scientific SE
Exova Group PLC
Intertek Pharmaceutical Services
Laboratory Testing Inc.
Pace Analytical Services LLC
Pharmaceutical Product Development, LLC
SGS SA
Steris PLC
Tentamus
Toxikon Inc.
West Pharmaceutical Services Inc.
WuXi AppTec, Inc.



This post first appeared on Newstrail.com, please read the originial post: here

Share the post

Pharma Testing Outsourcing Market: 8.4% CAGR and Cost-Effective Models

×

Subscribe to Newstrail.com

Get updates delivered right to your inbox!

Thank you for your subscription

×